Prognostic bioindicators in severe COVID-19 patients

BACKGROUND: Severe acute respiratory syndrome caused by novel coronavirus 2 (SARS-CoV-2) emerged in Wuhan (China) in December 2019. Here we evaluated a panel of biomarkers to phenotype patients and to define the role of immuno-inflammatory mediators as biomarkers of severity. MATERIALS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergantini, L., Bargagli, E., d'Alessandro, M., Refini, R.M., Cameli, P., Galasso, L., Scapellato, C., Montagnani, F., Scolletta, S., Franchi, F., Valente, S., Bennett, D., Sebastiani, G., Frediani, B., Dotta, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843114/
https://www.ncbi.nlm.nih.gov/pubmed/33548798
http://dx.doi.org/10.1016/j.cyto.2021.155455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843114/
https://www.ncbi.nlm.nih.gov/pubmed/33548798
http://dx.doi.org/10.1016/j.cyto.2021.155455

Ejemplares similares